medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2018, Number 1

<< Back Next >>

Ann Hepatol 2018; 17 (1)

Hepatic Hydrothorax

Lv Y, Han G, Fan D

Language: English
References: 131
Page: 33-46
PDF size: 205.52 Kb.


ABSTRACT

Hepatic hydrothorax (HH) is a pleural effusion that develops in a patient with cirrhosis and portal hypertension in the absence of cardiopulmonary disease. Although the development of HH remains incompletely understood, the most acceptable explanation is that the pleural effusion is a result of a direct passage of ascitic fluid into the pleural cavity through a defect in the diaphragm due to the raised abdominal pressure and the negative pressure within the pleural space. Patients with HH can be asymptomatic or present with pulmonary symptoms such as shortness of breath, cough, hypoxemia, or respiratory failure associated with large pleural effusions. The diagnosis is established clinically by finding a serous transudate after exclusion of cardiopulmonary disease and is confirmed by radionuclide imaging demonstrating communication between the peritoneal and pleural spaces when necessary. Spontaneous bacterial empyema is serious complication of HH, which manifest by increased pleural fluid neutrophils or a positive bacterial culture and will require antibiotic therapy. The mainstay of therapy of HH is sodium restriction and administration of diuretics. When medical therapy fails, the only definitive treatment is liver transplantation. Therapeutic thoracentesis, indwelling tunneled pleural catheters, transjugular intrahepatic portosystemic shunt and thoracoscopic repair of diaphragmatic defects with pleural sclerosis can provide symptomatic relief, but the morbidity and mortality is high in these extremely ill patients.


REFERENCES

  1. Machicao VI, Balakrishnan M, Fallon MB. Pulmonary complications in chronic liver disease. Hepatology 2014; 59: 1627-37.

  2. Cardenas A, Kelleher T, Chopra S. Review article: hepatic hydrothorax. Aliment Pharmacol Ther 2004; 20: 271-9.

  3. Chen TA, Lo GH, Lai KH. Risk factors for spontaneous bacterial empyema in cirrhotic patients with hydrothorax. J Chin Med Assoc2003; 66: 579-86.

  4. Liu WL, Kuo PH, Ku SC, Huang PM, Yang PC. Impact of therapeutic interventions onsurvival of patients with hepatic hydrothorax. J Formos Med Assoc2010; 109: 582-8.

  5. Morrow CS, Kantor M, Armen RN. Hepatic hydrothorax. Ann Intern Med 1958; 49: 193-203.

  6. Singh C, Sager JS. Pulmonary complications of cirrhosis. Med Clin North Am2009; 93: 871-83.

  7. Badillo R, Rockey DC. Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature. Medicine (Baltimore) 2014; 93: 135-42.

  8. Abbasi A, Bhutto AR, Alam MT, Aurangzaib M, Masroor M. Frequency of Hepatic Hydrothorax and its Association with Child Pugh Class in Liver Cirrhosis Patients. J Coll Physicians Surg Pak 2016; 26: 566-9.

  9. Kim JS, Kim CW, Nam HS, Cho JH, Ryu JS, Lee HL. Hepatic hydrothorax without ascites as the first sign of liver cirrhosis. Respirol Case Rep 2016; 4: 16-8.

  10. Al-Zoubi RK, Abu GM, Gohar A, Salzman GA, Yousef O. Hepatic hydrothorax: clinical review and update on consensus guidelines. Hosp Pract (1995) 2016; 44: 213-23.

  11. Borchardt J, Smirnov A, Metchnik L, Malnick S. Treating hepatic hydrothorax. BMJ 2003; 326: 751-2.

  12. Norvell JP, Spivey JR. Hepatic hydrothorax. Clin Liver Dis 2014; 18: 439-49.

  13. Gur C, Ilan Y, Shibolet O. Hepatic hydrothorax—pathophysiology, diagnosis and treatment—review of the literature. Liver Int 2004; 24: 281-4.

  14. Kiafar C, Gilani N. Hepatic hydrothorax: current concepts of pathophysiology and treatment options. Ann Hepatol 2008; 7: 313-20.

  15. Zenda T, Miyamoto S, Murata S, Mabuchi H. Detection of diaphragmatic defect as the cause of severe hepatic hydrothorax with magnetic resonance imaging. Am J Gastroenterol 1998; 93: 2288-9.

  16. Rubinstein D, McInnes IE, Dudley FJ. Hepatic hydrothorax in the absence of clinical ascites: diagnosis and management. Gastroenterology 1985; 88: 188-91.

  17. Gilsanz V, Emons D, Hansmann M, Meradji M, Donaldson JS, Omenaca F, Quero J, et al. Hydrothorax, ascites, and right diaphragmatic hernia. Radiology 1986; 158: 243-6.

  18. Huang PM, Chang YL, Yang CY, Lee YC. The morphology of diaphragmatic defects in hepatic hydrothorax: thoracoscopic finding. J Thorac Cardiovasc Surg 2005; 130: 141-5.

  19. Park CH, Pham CD. Hepatic hydrothorax. Scintigraphic confirmation. Clin Nucl Med 1995; 20: 278.

  20. Lin DJ, Zhang M, Gao GX, Li B, Wang MF, Zhu L, Xue LF. Thoracoscopy fordiagnosis and management of refractory hepatic hydrothorax. Chin Med J (Engl)2006; 119: 430-4.

  21. Krok KL, Cardenas A. Hepatic hydrothorax. Semin Respir Crit Care Med 2012; 33: 3-10.

  22. Kumar S, Kumar R. Hepatic hydrothorax: The shower within. J Bronchology Interv Pulmonol 2014; 21: 88-9.

  23. Dohmen K, Tanaka H, Haruno M, Niho Y. Hepatic hydrothorax occurring rapidly after manual abdominal compression. World J Gastroenterol 2007; 13: 6284-5.

  24. Ajmi S, Sfar R, Nouira M, Souguir A, Jmaa A, Golli L, Ben FM, et al. Role of the peritoneopleural pressure gradient in the genesis of hepatic hydrothorax. An isotopic study. Gastroenterol Clin Biol 2008; 32: 729-33.

  25. Bonacini M, Rammohan G. 99mTc-sulfur colloid studies in hepatic hydrothorax. Gastroenterology 1987; 92: 273.

  26. Ajmi S, Hassine H, Guezguez M, Elajmi S, Mrad DK, Karmani M, Zayane A, et al. Isotopic exploration of hepatic hydrothorax: ten cases. Gastroenterol Clin Biol 2004; 28: 462-6.

  27. Benet A, Vidal F, Toda R, Siurana R, De Virgala CM, Richart C. Diagnosis of hepatic hydrothorax in the absence of ascites by intraperitoneal injection of 99m-Tc-Fluor colloid. Postgrad Med J1992; 68: 153.

  28. Raju EP, Rao PN, Venkateswarlu J, Subhashini S. Ultrasound documentation of diaphragmatic rent in hepatic hydrothorax. Indian J Gastroenterol 1989; 8: 111-2.

  29. Foschi FG, Piscaglia F, Pompili M, Corbelli C, Marano G, Righini R, Alvisi V, et al. Real-time contrast-enhanced ultrasound— a new simple tool for detection of peritoneal-pleural communications in hepatic hydrothorax.Ultraschall Med 2008; 29: 538-42.

  30. Tamano M, Hashimoto T, Kojima K, Maeda C, Hiraishi H. Diagnosis of hepatic hydrothorax using contrast-enhanced ultrasonography with intraperitoneal injection of Sonazoid.J Gastroenterol Hepatol 2010; 25: 383-6.

  31. Matono T, Koda M, Murawaki Y. Right diaphragmatic defect in hepatic hydrothorax exposed by contrast-enhanced ultrasonography after radiofrequency ablation. Hepatology 2012; 56: 784-5.

  32. Rajnish A, Sudhakar P. Diagnosis of hepatic hydrothorax by Tc-99m sulfur colloid peritoneal scintigraphy. Clin Nucl Med 2001; 26: 888.

  33. Hewett LJ, Bradshaw ML, Gordon LL, Rockey DC. Diagnosis of isolated hepatic hydrothorax using peritoneal scintigraphy. Hepatology 2016; 64: 1364-6.

  34. Baikati K, Le DL, Jabbour II, Singhal S, Anand S. Hepatic hydrothorax. Am J Ther 2014; 21: 43-51.

  35. Jones EG. Hepatic hydrothorax: a retrospective case study. J Am Acad Nurse Pract 2001; 13: 209-14.

  36. Abbasi A, Bhutto AR, Alam MT, Aurangzaib M, Masroor M. Frequency of Hepatic Hydrothorax and its Association with Child Pugh Class in Liver Cirrhosis Patients. J Coll Physicians Surg Pak 2016; 26: 566-9.

  37. Roussos A, Philippou N, Mantzaris GJ, Gourgouliannis KI. Hepatic hydrothorax: pathophysiology diagnosis and management. J Gastroenterol Hepatol 2007; 22: 1388-93.

  38. Cardenas A, Arroyo V. Management of ascites and hepatic hydrothorax. Best Pract Res Clin Gastroenterol 2007; 21: 55-75.

  39. Gurung P, Goldblatt M, Huggins JT, Doelken P, Nietert PJ, Sahn SA. Pleural fluidanalysis and radiographic, sonographic, and echocardiographic characteristics of hepatic hydrothorax. Chest 2011; 140: 448-53.

  40. Xiol X, Castellote J, Cortes-Beut R, Delgado M, Guardiola J, Sese E. Usefulness and complications of thoracentesis in cirrhotic patients. Am J Med 2001; 111: 67-9.

  41. Xiol X, Guardiola J. Hepatic hydrothorax. Curr Opin Pulm Med 1998; 4: 239-42.

  42. Alonso JC. Pleural effusion in liver disease. Semin Respir Crit Care Med 2010; 31: 698-705.

  43. Bielsa S, Porcel JM, Castellote J,Mas E, Esquerda A, Light RW. Solving the Light’s criteria misclassification rate of cardiac and hepatic transudates. Respirology 2012; 17: 721-6.

  44. Porcel JM. Identifying transudates misclassified by Light’s criteria. Curr Opin Pulm Med 2013; 19: 362-7.

  45. Light RW. The undiagnosed pleural effusion. Clin Chest Med 2006; 27: 309-19.

  46. Bhuniya S. Was it really hepatic hydrothorax? Lancet 2010; 376: 1300, 1300-1301.

  47. Ackerman Z, Reynolds TB. Evaluation of pleural fluid in patients with cirrhosis. J Clin Gastroenterol 1997; 25: 619-22.

  48. Christoffersen S. CT verified cause of death in hepatic hydrothorax without ascites. Forensic Sci Int 2010; 198: e11- e13.

  49. Kaplan LM, Epstein SK, Schwartz SL, Cao QL, Pandian NG. Clinical, echocardiographic, and hemodynamic evidence of cardiac tamponade caused by large pleural effusions. Am J Respir Crit Care Med 1995; 151: 904-8.

  50. Shah A, Variyam E. Pericardial effusion and left ventricular dysfunction associated with ascites secondary to hepatic cirrhosis. Arch Intern Med 1988; 148: 585-8.

  51. Schuster DM, Mukundan SJ, Small W, Fajman WA. The use of the diagnostic radionuclide ascites scan to facilitate treatment decisions for hepatic hydrothorax. Clin Nucl Med 1998; 23: 16-8.

  52. Kim YK, Kim Y, Shim SS. Thoracic complications of liver cirrhosis: radiologic findings. Radiographics 2009; 29: 825-37.

  53. Flaum MA. Spontaneous bacterial empyema in cirrhosis. Gastroenterology1976; 70: 416-7.

  54. Tu CY, Chen CH. Spontaneous bacterial empyema. Curr Opin Pulm Med2012;18: 355-8.

  55. Xiol X, Castellote J, Baliellas C, Ariza J, Gimenez RA, Guardiola J, Casais L. Spontaneous bacterial empyema in cirrhotic patients: analysis of eleven cases. Hepatology 1990; 11: 365-70.

  56. Xiol X, Castellvi JM, Guardiola J, Sese E, Castellote J, Perello A, Cervantes X, et al. Spontaneous bacterial empyema in cirrhotic patients: a prospective study. Hepatology 1996; 23: 719-23.

  57. Murray HW, Marks SJ. Spontaneous bacterial empyema, pericarditis, and peritonitis in cirrhosis. Gastroenterology 1977; 72: 772-3.

  58. Ninan J, Fakhran S. Spontaneous Bacterial Empyema: Its Association With Liver Disease. Mayo Clin Proc 2016; 91: 537- 8.

  59. B SK, Balajinathan R, Alagavenkatesan AV, Balamurugan, Gurunamasivayam. Spontaneous bacterial empyema in cirrhosis, an underdiagnosed entity. J Assoc Physicians India 2016; 64: 104-5.

  60. Allam NA. Spontaneous bacterial empyema in liver cirrhosis: an underdiagnosed pleural complication. Saudi J Gastroenterol2008; 14: 43-5.

  61. Lam ST, Johnson ML, Kwok RM, Bassett JT. Spontaneous bacterial empyema: not your average empyema. Am J Med2014; 127: e9-e10.

  62. Nguyen TA, Liendo C, Owens MW. Counterpoint: does spontaneous bacterial empyema occur? No. Chest 2015; 147: 1208-10.

  63. Lai YK, Eiger G, Fischer RA. Point: doesspontaneous bacterial empyema occur? Yes. Chest2015; 147: 1207-8.

  64. Kumar S, Sarin SK. Paradigms in the management of hepatic hydrothorax: past, present, and future. Hepatol Int 2013; 7: 80-7.

  65. Sese E, Xiol X, Castellote J, Rodriguez-Farinas E, Tremosa G. Low complement levels and opsonic activity in hepatic hydrothorax: its relationship with spontaneous bacterial empyema. J Clin Gastroenterol 2003; 36: 75-7.

  66. Castellote J, Lopez C, Gornals J, Domingo A, Xiol X. Use of reagent strips for the rapiddiagnosis of spontaneous bacterial empyema. J Clin Gastroenterol 2005; 39: 278-81.

  67. Wang JT, Fang CT, Hsueh PR, Chang SC, Luh KT. Spontaneous bacterial empyema caused by Aeromonas veronii biotype sobria. Diagn Microbiol Infect Dis 2000; 37: 271-3.

  68. Chen CH, Shih CM, Chou JW, Liu YH, Hang LW, Hsia TC, Hsu WH, et al. Outcome predictors of cirrhotic patients with spontaneous bacterial empyema. Liver Int 2011; 31: 417-24.

  69. Hepokoski M, Makani SS, Lerner AD, Crotty AL. Spontaneous Pneumothorax Complicating Chronic Hepatic Hydrothorax: Successful Treatment by Small Bore Chest Tube. J Bronchology Interv Pulmonol 2016; 23: e43-e45.

  70. Liu LU, Haddadin HA, Bodian CA, Sigal SH, Korman JD, Bodenheimer HJ, Schiano TD. Outcome analysis of cirrhotic patients undergoing chest tube placement.Chest 2004; 126: 142-8.

  71. Runyon BA, Greenblatt M, Ming RH. Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol 1986; 81: 566-7.

  72. Porcel JM. Management of refractory hepatic hydrothorax. Curr Opin Pulm Med 2014; 20: 352-7.

  73. Singh A, Bajwa A, Shujaat A. Evidence-based review of the management of hepatic hydrothorax. Respiration 2013; 86: 155-73.

  74. Kinasewitz GT, Keddissi JI. Hepatic hydrothorax. Curr Opin Pulm Med 2003; 9: 261-5.

  75. Rossle M, Gerbes AL. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut 2010; 59: 988-1000.

  76. Argento AC, Murphy TE, Pisani MA, Araujo KL, Puchalski J. Patient-Centered Outcomes Following Thoracentesis. Pleura (Thousand Oaks) 2015; 2.

  77. Castellote J, Xiol X, Cortes-Beut R, Tremosa G, Rodriguez E, Vazquez S. Complications of thoracentesis in cirrhotic patients with pleural effusion. Rev Esp Enferm Dig 2001; 93: 566-75.

  78. Siddappa PK, Kar P. Hepatic hydrothorax. Trop Gastroenterol 2009; 30: 135-41.

  79. Orman ES, Lok AS. Outcomes of patients with chest tube insertion for hepatic hydrothorax. Hepatol Int 2009; 3: 582-6.

  80. Pfammatter R, Quattropani C, Reichen J, Goke B, Wagner AC. Treatment of hepatic hydrothorax and reduction of chest tube output with octreotide. Eur J Gastroenterol Hepatol 2001; 13: 977-80.

  81. Chen A, Massoni J, Jung D, Crippin J. Indwelling Tunneled Pleural Catheters for the Management of Hepatic Hydrothorax. A Pilot Study. Ann Am Thorac Soc 2016; 13: 862-6.

  82. Shah R, Succony L, Gareeboo S. Use of tunneled pleural catheters for the management of refractory hepatic hydrothorax. BMJ Case Rep 2011; 2011.

  83. Chee A, Tremblay A. The use of tunneled pleural catheters in the treatment of pleural effusions. Curr Opin Pulm Med 2011; 17: 237-41.

  84. Bhatnagar R, Reid ED, Corcoran JP, Bagenal JD, Pope S, Clive AO, Zahan-Evans N, et al. Indwelling pleural catheters for non-malignant effusions: a multicentre review of practice. Thorax 2014; 69: 959-61.

  85. Mercky P, Sakr L, Heyries L, Lagrange X, Sahel J, Dutau H. Use of a tunnelled pleural catheter for the management of refractory hepatic hydrothorax: a new therapeutic option. Respiration 2010; 80: 348-52.

  86. Shah R, SucconyL, Gareeboo S. Use of tunneled pleural catheters for the management of refractory hepatic hydrothorax. BMJ Case Rep 2011; 2011.

  87. Chee A, Tremblay A. The use of tunneled pleural catheters in the treatment of pleural effusions. Curr Opin Pulm Med 2011; 17: 237-41.

  88. Mercky P, Sakr L, Heyries L, Lagrange X, Sahel J, Dutau H. Use of a tunnelled pleural catheter for the management of refractory hepatic hydrothorax: a new therapeutic option. Respiration 2010; 80: 348-52.

  89. Patil M, Dhillon SS, Attwood K, Saoud M, Alraiyes AH, Harris K. Management of Benign Pleural Effusions Using Indwelling Pleural Catheters: A Systematic Review and Meta-analysis. Chest 2017; 151: 626-35.

  90. Mirrakhimov AE, Ayach T, Gray A. Indwelling Tunneled Pleural Catheters for the Management of Hepatic Hydrothorax: A Word of Caution. Ann Am Thorac Soc 2016; 13: 1432.

  91. Haas KP, Chen AC. Indwelling tunneled pleural catheters for the management of hepatic hydrothorax. Curr Opin Pulm Med2017; 23: 351-6.

  92. Gordon FD, Anastopoulos HT, Crenshaw W, Gilchrist B, McEniff N, Falchuk KR, LoCicero JR, et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology 1997; 25: 1366-9.

  93. Parker R, Armstrong MJ, Rowe IA, Houlihan DD. Estimated short-term mortality following TIPS insertion for patients with hepatic hydrothorax. Am J Gastroenterol 2013; 108: 1806-7.

  94. Dhanasekaran R, West JK, Gonzales PC, Subramanian R, Parekh S, Spivey JR, Martin LG, et al. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis. Am J Gastroenterol 2010; 105: 635-41.

  95. Haskal ZJ, Zuckerman J. Resolution of hepatic hydrothorax after transjugular intrahepatic portosystemic shunt (TIPS) placement. Chest 1994; 106: 1293-5.

  96. Strauss RM, Martin LG, Kaufman SL, Boyer TD. Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol 1994; 89: 1520-2.

  97. Conklin LD, Estrera AL, Weiner MA, Reardon PR, Reardon MJ. Transjugular intrahepatic portosystemic shunt for recurrent hepatic hydrothorax. Ann Thorac Surg 2000; 69: 609-11.

  98. Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rossle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol 2001; 13: 529-34.

  99. Ditah IC, Al BB, Saberi B, Ditah C, Kamath PS. Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: A systematic review and cumulative meta-analysis. World J Hepatol 2015; 7: 1797-806.

  100. 100.Campos S, Gomes D, Sofia C. Transjugular intrahepatic portosystemic shunt in refractory hydrothorax -a contributionto an unexplored indication. Eur J Gastroenterol Hepatol 2016; 28: 661-6.

  101. 101.Holster IL, Tjwa ET, Moelker A, Wils A, Hansen BE, Vermeijden JR, Scholten P, et al. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + betablocker for prevention of variceal rebleeding. Hepatology2016; 63: 581-9.

  102. 102.Bureau C, Pagan JC, Layrargues GP, Metivier S, Bellot P, Perreault P, Otal P, et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int2007; 27: 742-7.

  103. 103.Yang Z, Han G, Wu Q, Ye X, Jin Z, Yin Z, Qi X, et al. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J Gastroenterol Hepatol 2010; 25: 1718-25.

  104. 104.Riggio O, Angeloni S, Salvatori FM, De Santis A, Cerini F, Farcomeni A, Attili AF, et al. Incidence, natural history, and risk factorsof hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene- covered stent grafts. Am J Gastroenterol 2008; 103: 2738-46.

  105. 105.Rossle M. TIPS: 25 years later. J Hepatol2013; 59: 1081-93.

  106. 106.Spencer EB, Cohen DT, Darcy MD. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax. J Vasc Interv Radiol 2002; 13: 385-90.

  107. 107.Cerfolio RJ, Bryant AS. Efficacy of video-assisted thoracoscopic surgery with talc pleurodesis for porous diaphragm syndrome in patients with refractory hepatic hydrothorax. Ann Thorac Surg 2006; 82: 457-9.

  108. 108.Lin PY, Kuo PH, Yu CJ, Yang PC. Long-term remission of hepatic hydrothorax after OK-432 pleurodesis. J Thorac CardiovascSurg2008; 136: 1367-9.

  109. 109.Northup PG, Harmon RC, Pruett TL, Schenk WR, Daniel TM, Berg CL. Mechanical pleurodesis aided by peritoneal drainage: procedure for hepatic hydrothorax. Ann Thorac Surg 2009; 87: 245-50.

  110. 110.Helmy N, Akl Y, Kaddah S, Hafiz HA, Makhzangy HE. A case series: Egyptian experience in using chemical pleurodesis as an alternative management in refractory hepatic hydrothorax. Arch Med Sci 2010; 6: 336-42.

  111. 111.Lee WJ, Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, et al. Chemical pleurodesis for the management of refractory hepatic hydrothorax in patients with decompensated liver cirrhosis. Korean J Hepatol 2011; 17: 292-8.

  112. 112.Goto T, Oyamada Y, Hamaguchi R, Shimizu K, Kubota M, Akanabe K, Kato R. Remission of hepatic hydrothoraxafter OK-432 pleurodesis. Ann Thorac Cardiovasc Surg 2011; 17: 208-11.

  113. 113.Ferrante D, Arguedas MR, Cerfolio RJ, Collins BG, van Leeuwen DJ. Video-assisted thoracoscopic surgery with talc pleurodesis in the management of symptomatic hepatic hydrothorax. Am J Gastroenterol 2002; 97: 3172-5.

  114. 114.Porcel JM. Management of refractory hepatic hydrothorax. Curr Opin Pulm Med2014; 20: 352-7.

  115. 115.Chalhoub M, Harris K, Castellano M, Maroun R, Bourjeily G. The use of the PleurX catheter in the management of nonmalignant pleural effusions. Chron Respir Dis2011; 8: 185- 91.

  116. 116.Harris K, Chalhoub M. The use of a PleurX catheter in the management of recurrent benign pleural effusion: a concise review. Heart Lung Circ 2012; 21: 661-5.

  117. 117.Saito R, Rai T, Saito H, Abe K, Takahashi A, Takiguchi J, Ohira H. Two cases of intractable hepatic hydrothorax successfully treated with nasal CPAP. Nihon Shokakibyo Gakkai Zasshi 2006; 103: 1146-51.

  118. 118.Hou F, Qi X, Guo X. Effectiveness and Safety of Pleurodesis for Hepatic Hydrothorax: A Systematic Review and Meta- Analysis. Dig Dis Sci 2016; 61: 3321-34.

  119. 119.Porcel JM. Management of refractory hepatic hydrothorax. Curr Opin Pulm Med 2014; 20: 352-7.

  120. 120.Mouroux J, Perrin C, Venissac N, Blaive B, Richelme H. Management of pleural effusion of cirrhotic origin.Chest 1996; 109: 1093-6.

  121. 121.Milanez DCJ, Filho LO, de Campos WE, Sette HJ, Fernandez A, Filomeno LT, Jatene FB. Thoracoscopy and talc poudrage in the management of hepatic hydrothorax. Chest 2000; 118: 13-7.

  122. 122.NakamuraY, Iwazaki M, Yasui N, Seki H, Matsumoto H, Masuda R, Nishiumi N, et al. Diaphragmatic repair of hepatic hydrothorax with VATS after abdominal insufflation with CO(2). Asian J Endosc Surg 2012; 5: 141-4.

  123. 123.Luh SP, Chen CY. Video-assisted thoracoscopic surgery (VATS) for the treatment of hepatic hydrothorax: report of twelve cases. J Zhejiang Univ Sci B2009; 10: 547-51.

  124. 124.Huang PM, Kuo SW, Lee JM. Thoracoscopic diaphragmatic repair for refractory hepatic hydrothorax: application of pleural flap and mesh onlay reinforcement. Thorac Cardiovasc Surg2006; 54: 47-50.

  125. 125.Huang PM, Kuo SW, Chen JS, Lee JM. Thoracoscopic Mesh Repair of Diaphragmatic Defects in Hepatic Hydrothorax: A 10-Year Experience. Ann Thorac Surg 2016; 101: 1921-7.

  126. 126.Huang Y, Gloviczki P, Duncan AA, Fleming MD, Driscoll DJ, Kalra M, Oderich GS, et al. Management of refractory chylous ascites with peritoneovenous shunts. J Vasc Surg Venous Lymphat Disord 2017; 5: 538-46.

  127. 127.Kim JK, Maynulet R, Goldfarb A. Use of Denver shunt in recurrent hepatic hydrothorax. Postgrad Med1982; 71: 236-7, 240-1.

  128. 128.Montanari M, Orsi P, Pugliano G. Hepatic hydrothorax without diaphragmatic defect. An original surgical treatment.J Cardiovasc Surg (Torino) 1996; 37: 425-7.

  129. 129.Ghandour E, Carter J, Feola M, Nugent KM. Management of hepatic hydrothorax with a peritoneovenous (Denver) shunt. South Med J 1990; 83: 718-9.

  130. 130.Bayram AS, Koprucuoglu M, Aygun M, Gebitekin C. Pleurovenous shunt for treating refractory benign pleural effusion. Eur J Cardiothorac Surg 2008; 33: 942-3.

  131. 131.Park SZ, Shrager JB, Allen MS, Nagorney DM. Treatment of refractory, nonmalignant hydrothorax with a pleurovenous shunt. Ann Thorac Surg 1997; 63: 1777-9. 132.Artemiou O, Marta GM, Klepetko W, Wolner E, Muller MR. Pleurovenous shunting in the treatment of nonmalignant pleural effusion. Ann Thorac Surg 2003; 76: 231-3. 133.Hadsaitong D, Suttithawil W. Pleurovenous shunt in treating refractory nonmalignant hepatic hydrothorax: a case report. Respir Med 2005; 99: 1603-05. 134.Perera E, Bhatt S, Dogra VS. Complications of Denver shunt. J Clin Imaging Sci 2011; 1: 6. 135.Krowka MJ, Wiesner RH, Heimbach JK. Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward. J Hepatol 2013; 59: 367-74. 136.Xiol X, Tremosa G, Castellote J, Gornals J, Lama C, Lopez C, Figueras J. Liver transplantation in patients with hepatic hydrothorax. Transpl Int 2005; 18: 672-5. 137.Serste T, Moreno C, Francoz C, Razek WA, Paugham C, Belghitti J, Valla D, et al. The impact of preoperative hepatic hydrothorax on the outcome of adult liver transplantation. Eur J Gastroenterol Hepatol 2010; 22: 207-12. 138.Endo K, Iida T, Yagi S, Yoshizawa A, Fujimoto Y, Ogawa K, Ogura Y, et al. Impact of preoperative uncontrollable hepatic hydrothorax and massive ascites in adult liver transplantation. Surg Today 2014; 44: 2293-9. 139.Bozbas SS, Eyuboglu F. Evaluation of liver transplant candidates: A pulmonary perspective. Ann Thorac Med 2011; 6: 109-14.




2020     |     www.medigraphic.com